TY - JOUR
T1 - Association of common genetic variants with brain microbleeds
T2 - A genome-wide association study
AU - Alzheimer's Disease Neuroimaging Initiative
AU - Knol, Maria J
AU - Lu, Dongwei
AU - Traylor, Matthew
AU - Adams, Hieab H H
AU - Romero, José Rafael J
AU - Smith, Albert V
AU - Fornage, Myriam
AU - Hofer, Edith
AU - Liu, Junfeng
AU - Hostettler, Isabel C
AU - Luciano, Michelle
AU - Trompet, Stella
AU - Giese, Anne-Katrin
AU - Hilal, Saima
AU - van den Akker, Erik B
AU - Vojinovic, Dina
AU - Li, Shuo
AU - Sigurdsson, Sigurdur
AU - van der Lee, Sven J
AU - Jack, Clifford R
AU - Wilson, Duncan
AU - Yilmaz, Pinar
AU - Satizabal, Claudia L
AU - Liewald, David C M
AU - van der Grond, Jeroen
AU - Chen, Christopher
AU - Saba, Yasaman
AU - van der Lugt, Aad
AU - Bastin, Mark E
AU - Windham, B Gwen
AU - Cheng, Ching Yu
AU - Pirpamer, Lukas
AU - Kantarci, Kejal
AU - Himali, Jayandra J
AU - Yang, Qiong
AU - Morris, Zoe
AU - Beiser, Alexa S
AU - Tozer, Daniel J
AU - Vernooij, Meike W
AU - Amin, Najaf
AU - Beekman, Marian
AU - Koh, Jia Yu
AU - Stott, David J
AU - Houlden, Henry
AU - Schmidt, Reinhold
AU - Gottesman, Rebecca F
AU - MacKinnon, Andrew D
AU - DeCarli, Charles
AU - Gudnason, Vilmundur
AU - Deary, Ian J
N1 - Copyright © 2020 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology.
PY - 2020/12/15
Y1 - 2020/12/15
N2 - OBJECTIVE: To identify common genetic variants associated with the presence of brain microbleeds (BMBs).METHODS: We performed genome-wide association studies in 11 population-based cohort studies and 3 case-control or case-only stroke cohorts. Genotypes were imputed to the Haplotype Reference Consortium or 1000 Genomes reference panel. BMBs were rated on susceptibility-weighted or T2*-weighted gradient echo MRI sequences, and further classified as lobar or mixed (including strictly deep and infratentorial, possibly with lobar BMB). In a subset, we assessed the effects of APOE ε2 and ε4 alleles on BMB counts. We also related previously identified cerebral small vessel disease variants to BMBs.RESULTS: BMBs were detected in 3,556 of the 25,862 participants, of which 2,179 were strictly lobar and 1,293 mixed. One locus in the APOE region reached genome-wide significance for its association with BMB (lead single nucleotide polymorphism rs769449; odds ratio [OR]any BMB [95% confidence interval (CI)] 1.33 [1.21-1.45]; p = 2.5 × 10-10). APOE ε4 alleles were associated with strictly lobar (OR [95% CI] 1.34 [1.19-1.50]; p = 1.0 × 10-6) but not with mixed BMB counts (OR [95% CI] 1.04 [0.86-1.25]; p = 0.68). APOE ε2 alleles did not show associations with BMB counts. Variants previously related to deep intracerebral hemorrhage and lacunar stroke, and a risk score of cerebral white matter hyperintensity variants, were associated with BMB.CONCLUSIONS: Genetic variants in the APOE region are associated with the presence of BMB, most likely due to the APOE ε4 allele count related to a higher number of strictly lobar BMBs. Genetic predisposition to small vessel disease confers risk of BMB, indicating genetic overlap with other cerebral small vessel disease markers.
AB - OBJECTIVE: To identify common genetic variants associated with the presence of brain microbleeds (BMBs).METHODS: We performed genome-wide association studies in 11 population-based cohort studies and 3 case-control or case-only stroke cohorts. Genotypes were imputed to the Haplotype Reference Consortium or 1000 Genomes reference panel. BMBs were rated on susceptibility-weighted or T2*-weighted gradient echo MRI sequences, and further classified as lobar or mixed (including strictly deep and infratentorial, possibly with lobar BMB). In a subset, we assessed the effects of APOE ε2 and ε4 alleles on BMB counts. We also related previously identified cerebral small vessel disease variants to BMBs.RESULTS: BMBs were detected in 3,556 of the 25,862 participants, of which 2,179 were strictly lobar and 1,293 mixed. One locus in the APOE region reached genome-wide significance for its association with BMB (lead single nucleotide polymorphism rs769449; odds ratio [OR]any BMB [95% confidence interval (CI)] 1.33 [1.21-1.45]; p = 2.5 × 10-10). APOE ε4 alleles were associated with strictly lobar (OR [95% CI] 1.34 [1.19-1.50]; p = 1.0 × 10-6) but not with mixed BMB counts (OR [95% CI] 1.04 [0.86-1.25]; p = 0.68). APOE ε2 alleles did not show associations with BMB counts. Variants previously related to deep intracerebral hemorrhage and lacunar stroke, and a risk score of cerebral white matter hyperintensity variants, were associated with BMB.CONCLUSIONS: Genetic variants in the APOE region are associated with the presence of BMB, most likely due to the APOE ε4 allele count related to a higher number of strictly lobar BMBs. Genetic predisposition to small vessel disease confers risk of BMB, indicating genetic overlap with other cerebral small vessel disease markers.
KW - Aged
KW - Aged, 80 and over
KW - Alleles
KW - Apolipoprotein E2/genetics
KW - Apolipoprotein E4/genetics
KW - Apolipoproteins E/genetics
KW - Case-Control Studies
KW - Cerebral Hemorrhage/diagnostic imaging
KW - Cerebral Small Vessel Diseases/epidemiology
KW - Cohort Studies
KW - Female
KW - Genetic Predisposition to Disease
KW - Genome-Wide Association Study
KW - Humans
KW - Magnetic Resonance Imaging
KW - Male
KW - Middle Aged
KW - Polymorphism, Single Nucleotide
KW - Risk
KW - White Matter/diagnostic imaging
U2 - https://doi.org/10.1212/WNL.0000000000010852
DO - https://doi.org/10.1212/WNL.0000000000010852
M3 - Article
C2 - 32913026
SN - 0028-3878
VL - 95
SP - e3331-e3343
JO - Neurology
JF - Neurology
IS - 24
ER -